Literature DB >> 25796180

Effects of oxytocin on the fear memory reconsolidation.

Yu Hou1, Liyan Zhao2, Genai Zhang1, Lixiang Ding3.   

Abstract

Oxytoxin (OT) promotes social behavior and reduces anxiety. A great number of studies suggest that OT plays a role in learning and memory processes in animals and humans. Fear memories are rendered labile and prone to modification after reactivation and a restabilization and reconsolidation process is necessary for future memory conservation. This process is crucial for modulation of an existing memory and forms a promising therapeutic target for pathological memory disorders. In this study, we investigated whether a single systemic injection of OT has effects on reconsolidation of fear memories. We found post-reactivation administration of OT impairs reconsolidation of these memories and the impairment effect is reactivation-dependent. Postreactivation short-term fear memories and the learning of new fear memory were unaffected by OT. The study demonstrates the effectiveness of OT in persistently impairing fear memory retention by blocking reconsolidation in rats. OT administration after retrieval of fear memories may open a new avenue to treat pathological memory-related disorders.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fear memory; Oxytocin; Reactivation; Reconsolidation

Mesh:

Substances:

Year:  2015        PMID: 25796180     DOI: 10.1016/j.neulet.2015.03.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

Review 1.  Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects.

Authors:  Wadih Jean Naja; Michaelangelo Pietro Aoun
Journal:  Curr Psychiatry Rep       Date:  2017-08-15       Impact factor: 5.285

2.  Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial.

Authors:  Christopher S Stauffer; Tyler E Morrison; Nathan K Meinzer; David Leung; Jessica Buffington; Evan G Sheh; Thomas C Neylan; Aoife O'Donovan; Joshua D Woolley
Journal:  Psychiatry Res       Date:  2021-12-12       Impact factor: 11.225

3.  Post-retrieval oxytocin facilitates next day extinction of threat memory in humans.

Authors:  Jingchu Hu; Zijie Wang; Xiaoyi Feng; Cheng Long; Daniela Schiller
Journal:  Psychopharmacology (Berl)       Date:  2018-10-29       Impact factor: 4.530

4.  Modification of Fear Memory by Pharmacological and Behavioural Interventions during Reconsolidation.

Authors:  Janine Thome; Georgia Koppe; Sophie Hauschild; Lisa Liebke; Christian Schmahl; Stefanie Lis; Martin Bohus
Journal:  PLoS One       Date:  2016-08-18       Impact factor: 3.240

Review 5.  Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review.

Authors:  Ursula Stockhorst; Martin I Antov
Journal:  Front Behav Neurosci       Date:  2016-01-26       Impact factor: 3.558

6.  Oxytocin differentially modulates pavlovian cue and context fear acquisition.

Authors:  Juliana Cavalli; Michaela Ruttorf; Mario Rosero Pahi; Francesca Zidda; Herta Flor; Frauke Nees
Journal:  Soc Cogn Affect Neurosci       Date:  2017-06-01       Impact factor: 3.436

7.  Influence of intranasal oxytocin on fear consolidation in healthy humans.

Authors:  Elizabeth Hoge; Eric Bui; Peter Rosencrans; Scott Orr; Rachel Ross; Rebecca Ojserkis; Naomi Simon
Journal:  Gen Psychiatr       Date:  2019-12-18

8.  Emotional remodeling with oxytocin durably rescues trauma-induced behavioral and neuro-morphological changes in rats: a promising treatment for PTSD.

Authors:  Claire Le Dorze; Antonella Borreca; Annabella Pignataro; Martine Ammassari-Teule; Pascale Gisquet-Verrier
Journal:  Transl Psychiatry       Date:  2020-01-27       Impact factor: 6.222

9.  Evaluation of an angiotensin Type 1 receptor blocker on the reconsolidation of fear memory.

Authors:  Adam P Swiercz; Laxmi Iyer; Zhe Yu; Allison Edwards; N M Prashant; Bryan N Nguyen; Anelia Horvath; Paul J Marvar
Journal:  Transl Psychiatry       Date:  2020-10-27       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.